Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis
Abstract Objective To analyze the efficacy and safety of antiplatelet drugs combined with new oral anticoagulants (noac) in the treatment of coronary atherosclerotic heart disease (CAD). Methods The randomized controlled trials of noac combined with antiplatelet therapy in Cochrane, CNKI, PubMed, EM...
Main Authors: | Alimila Saiyitijiang, Mayila Aizezi, Ying Zhao, Ying Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | Annals of Noninvasive Electrocardiology |
Subjects: | |
Online Access: | https://doi.org/10.1111/anec.12977 |
Similar Items
-
Pharmacodynamic safety of clopidogrel monotherapy in patients under oral anticoagulation with a vitamin K antagonist undergoing coronary stent implantation
by: Christian Valina, et al.
Published: (2019-08-01) -
Establishing the correct management in a patient with multiple cryptogenic strokes: Antiplatelet vs. anticoagulant therapy
by: Ioan-Cristian Lupescu, et al.
Published: (2017-09-01) -
Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation
by: Francesca Romana Pezzella, et al.
Published: (2022-07-01) -
Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01) -
Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01)